Joseph Murray

Oct 9, 2024 | nature.com | Ferdinandos Skoulidis |Ana Cobo |Meagan Montesion |Yi Yu |Natalie I. Vokes |Joseph Murray | +44 more

AbstractFor patients with advanced non-small-cell lung cancer (NSCLC), dual immune checkpoint blockade (ICB) with CTLA4 inhibitors and PD-1 or PD-L1 inhibitors (hereafter, PD-(L)1 inhibitors) is associated with higher rates of anti-tumour activity and immune-related toxicities, when compared with treatment with PD-(L)1 inhibitors alone. However, there are currently no validated biomarkers to identify which patients will benefit from dual ICB1,2.

Mar 15, 2024 | independent.ie | Joseph Murray

Johnny Kenny strikes late to sink Galway and end Shamrock Rovers’ winless runGalway United 0 Shamrock Rovers 1Shamrock Rovers goalkeeper Leon Pohls makes a save during the Tallaght side's victory over Galway United at Eamonn Deacy Park. Photo: Piaras Ó Mídheach/SportsfileA late goal by substitute Johnny Kenny was enough to give Shamrock Rovers their first league win of the season against Galway United at Eamonn Deacy Park.

Mar 8, 2024 | msn.com | Joseph Murray

These cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

Mar 8, 2024 | independent.ie | Joseph Murray

Galway United 0 Drogheda United 0Galway United endured a frustrating night against a resolute Drogheda United defence in a goalless draw at Eamonn Deacy Park. Stephen Walsh, back in Galway’s starting XI after serving a three-game suspension, looked the most likely to score on a night of few chances. An early goalmouth scramble saw the Tribesmen’s close-range effort cleared as the home side settled into a rhythm of applying pressure on the Drogheda backline which endured for much of the encounter.

Jun 27, 2023 | onclive.com | Joseph Murray

Joseph Christopher Murray, MD, PhD, co-director, Lung Cancer Precision Medicine Center of Excellence, Instructor of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, discusses the investigation of peripheral myeloid cells as prognostic markers in patients with non–small cell lung cancer (NSCLC) treated with cemiplimab (Libtayo).